healthŌme, a Huntsville, AL-based genomics-based precision health management company, raised an undisclosed amount in Seed funding.
The round was led by American Family Ventures (AFV) and AllegisNL Capital.
The company intends to use the funds to enhance its offerings in the life and critical illness insurance sectors.
Led by CEO Darren Rowe, healthŌme is a genomics-based precision-health navigation company operating at the intersection of life insurance, life science, and health management. With a fully integrated, in-house genetics lab, the company is dedicated to simplifying and accelerating access to technologies and services to help cancer patients. The company, in partnership with Hannover Re US, the reinsurer for healthŌme’s cancer management program, designs and delivers tech-enabled, precision health management solutions through a network of life and critical insurance carriers.
healthŌme and its subsidiary, Kailos Genetics, are based at the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama.
FinSMEs
22/05/2024